Literature DB >> 12244188

Divergent role for TNF-alpha in IFN-gamma-induced killing of Toxoplasma gondii and Salmonella typhimurium contributes to selective susceptibility of patients with partial IFN-gamma receptor 1 deficiency.

Riny Janssen1, Annelies Van Wengen, Els Verhard, Tjitske De Boer, Timo Zomerdijk, Tom H M Ottenhoff, Jaap T Van Dissel.   

Abstract

Patients with defects in IFN-gamma- or IL-12-mediated immunity are susceptible to infections with Salmonella and non-tuberculous mycobacteria, but rarely suffer from infections with other intracellular pathogens such as Toxoplasma gondii. Here we describe macrophage and T cell function in eight individuals with partial IFN-gamma receptor 1 (IFN-gammaR1) deficiency due to a mutation that results in elevated cell surface expression of a truncated IFN-gammaR1 receptor that lacks the intracellular domain. We show that various effector mechanisms dependent on IFN-gammaR signaling are affected to different extents. Whereas TNF-alpha production was normally up-regulated in response to IFN-gamma, IL-12 production and CD64 up-regulation were strongly reduced, and IFN-gamma-mediated killing of the intracellular pathogens Salmonella typhimurium and T. gondii was completely abrogated in patient's macrophages. Since these patients suffer selectively from infections with non-tuberculous mycobacteria and Salmonella, but not T. gondii, despite sero-immunity in six of eight patients, which indicates previous contact with this pathogen, we next studied the role of TNF-alpha as a possible immune compensatory mechanism. IFN-gamma-induced killing of T. gondii appeared to be partially mediated by TNF-alpha, and addition of TNF-alpha could compensate for the abrogated killing of T. gondii in the patient's macrophages. In contrast, IFN-gamma-mediated killing of S. typhimurium appeared to be independent of TNF-alpha. We propose that the divergent role of TNF-alpha in IFN-gamma-induced killing of T. gondii and S. typhimurium may at least partially explain the highly selective susceptibility of patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244188     DOI: 10.4049/jimmunol.169.7.3900

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes.

Authors:  Rosa M Andrade; Matthew Wessendarp; Marc-Jan Gubbels; Boris Striepen; Carlos S Subauste
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

2.  CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon.

Authors:  Carlos S Subauste; Matthew Wessendarp
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

Review 3.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

4.  Gamma interferon enhances internalization and early nonoxidative killing of Salmonella enterica serovar Typhimurium by human macrophages and modifies cytokine responses.

Authors:  Melita A Gordon; Dominic L Jack; David H Dockrell; Margaret E Lee; Robert C Read
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 5.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

6.  Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo.

Authors:  Jennifer E Lykens; Catherine E Terrell; Erin E Zoller; Senad Divanovic; Aurelien Trompette; Christopher L Karp; Julio Aliberti; Matthew J Flick; Michael B Jordan
Journal:  J Immunol       Date:  2009-12-14       Impact factor: 5.422

7.  Influenza virus vaccination induces interleukin-12/23 receptor beta 1 (IL-12/23R beta 1)-independent production of gamma interferon (IFN-gamma) and humoral immunity in patients with genetic deficiencies in IL-12/23R beta 1 or IFN-gamma receptor I.

Authors:  Tjitske de Boer; Jaap T van Dissel; Taco W J Kuijpers; Guus F Rimmelzwaan; Frank P Kroon; Tom H M Ottenhoff
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

Review 8.  Infections in patients with inherited defects in phagocytic function.

Authors:  Timothy Andrews; Kathleen E Sullivan
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

9.  Early interferon-γ production in human lymphocyte subsets in response to nontyphoidal Salmonella demonstrates inherent capacity in innate cells.

Authors:  Tonney S Nyirenda; Anna E Seeley; Wilson L Mandala; Mark T Drayson; Calman A MacLennan
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

Review 10.  CD40 and the immune response to parasitic infections.

Authors:  Carlos S Subauste
Journal:  Semin Immunol       Date:  2009-07-18       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.